Episode 333 hosts Mike Clague (Nurse Injector from Melbourne, Australia)

In 'The Tox Talks' episodes we feature expert injectors who have significant experience in using botulinum toxins. These episodes explore our guests experiences using particular brands, the evolution of their injecting techniques and we get special insights into the subtle nuances of getting the best out of toxins.

In chapter 11 we talk about Relfydess, a new Botulinum Toxin A manufactured by Galderma.

We first re-introduce Mike (previously on episode 276) and his clinical background. We then cover his involvement in the pre-launch trials using Relfydess and his clinical experience with the product. We covers the efficacy and onset of Relfydess compared to other toxins, its performance in various facial areas, and discuss practical tips for injectors.

00:00 Introduction and Podcast Overview 00:40 Welcome to Chapter 11: The Tox Talks 00:53 Introducing Mike Clague and Relfydess Toxin 01:28 Mike's Background and Experience 03:31 Discussion on Toxin Efficacy and Longevity 06:20 Practical Insights and Injection Techniques 12:53 Patient Experiences and Feedback 24:10 Manufacturing and Purity of Toxins 27:09 Discussion on Antibody Levels 27:44 Patient Reactions to Treatment Onset 28:24 Dosage and Treatment Techniques 31:00 Commercial Implications of Treatment Frequency 32:34 Longevity and Variability of Treatment Effects 42:57 Training and Mentorship in Medical Practice 46:53 Regulations and Compliance in Medical Advertising 50:07 Final Thoughts and Farewell

ALL IA LINKS & CONTACT INFORMATION

Episode 246 -- NAVEX's Global Hotline Benchmarking Report